International Journal of Cardiology
Volume 136, Issue 2 , Pages 165-170 , 14 August 2009

Effects of intracoronary compared to intravenous abciximab administration in patients undergoing transradial percutaneous coronary intervention: A sub-analysis of the EASY trial

Received 25 December 2007 ,Revised 5 April 2008 ,Accepted 23 April 2008.

References 

  1. Romagnoli E, Burzotta F, Trani C, Biondi-Zoccai GG, Giannico F, Crea F. Rationale for intracoronary administration of abciximab. J Thromb Thrombolysis. 2007;23(1):57–63
  2. Sharma S, Makkar R, Lardizabal J. Intracoronary administration of abciximab during percutaneous coronary interventions: should this be the routine and preferred approach?. J Cardiovasc Pharmacol Ther. 2006;11(2):136–141
  3. Bellandi F, Maioli M, Gallopin M, Toso A, Dabizzi RP. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention. Catheter Cardiovasc Interv. 2004;62(2):186–192
  4. Galache Osuna JG, Sanchez-Rubio J, Calvo I, Diarte JA, Lukic A, Placer LJ. Does intracoronary abciximab improve the outcome of percutaneous coronary interventions? A randomized controlled trial. Rev Esp Cardiol. 2006;59(6):567–574
  5. Kakkar AK, Moustapha A, Hanley HG, et al. Comparison of intracoronary vs. intravenous administration of abciximab in coronary stenting. Catheter Cardiovasc Interv. 2004;61(1):31–34
  6. Wohrle J, Grebe OC, Nusser T, et al. Reduction of major adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty. Circulation. 2003;107(14):1840–1843
  7. Bertrand OF, De Larochelliere R, Rodes-Cabau J, et al. A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation. Circulation. 2006;114(24):2636–2643
  8. Mangin L, Bertrand OF, De La Rochelliere R, et al. The transulnar approach for coronary intervention: a safe alternative to transradial approach in selected patients. J Invasive Cardiol. 2005;17(2):77–79
  9. Cannon CP, Battler A, Brindis RG, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol. 2001;38(7):2114–2130
  10. Collet JP, Montalescot G, Lesty C, et al. Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention. Circulation. 2001;103(19):2328–2331
  11. Collet JP, Montalescot G, Lesty C, et al. Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis. Arterioscler Thromb Vasc Biol. 2001;21(1):142–148
  12. Marciniak SJ, Mascelli MA, Furman MI, et al. An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregates. Thromb Haemost. 2002;87(6):1020–1025
  13. Bertrand OF, Meerkin D, de Guise P, Crepeau J, Bourassa MG. Double vessel occlusions after balloon angioplasty treated by stenting and subsequently by abciximab infusion. Can J Cardiol. 2000;16(1):83–85
  14. Romagnoli E, Burzotta F, Trani C, et al. Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI. Int J Cardiol. 2005;105(3):250–255
  15. Deibele AJ, Kirtane AJ, Pinto DS, et al. Intracoronary bolus administration of eptifibatide during percutaneous coronary stenting for non ST elevation myocardial infarction and unstable angina. J Thromb Thrombolysis. 2006;22(1):47–50
  16. Pinto DS, Kirtane AJ, Ruocco NA, et al. Administration of intracoronary eptifibatide during ST-elevation myocardial infarction. Am J Cardiol. 2005;96(11):1494–1497
  17. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet. 2006;367(9510):569–578
  18. Gershlick AH, Stephens-Lloyd A, Hughes S, et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med. 2005;353(26):2758–2768
  19. Sezer M, Oflaz H, Goren T, et al. Intracoronary streptokinase after primary percutaneous coronary intervention. N Engl J Med. 2007;356(18):1823–1834
  20. Bertrand OF. A Randomized Trial of Early Discharge After Trans-Radial Stenting of Coronary Arteries in Acute Myocardial Infarction: The EASY-MI Pilot Study. http://www.clinicaltrials.gov/ct2/show/NCT00440778November 20 2007;accessed
  21. Bertrand OF. A Randomized Trial of Early Discharge After Trans-Radial Stenting of Coronary Arteries in Acute Myocardial Infarction and RESCUE-PCI: The EASY-RESCUE Pilot Study. http://www.clinicaltrials.gov/ct2/show/NCT00440895November 20 2007;accessed

PII: S0167-5273(08)00619-0

doi: 10.1016/j.ijcard.2008.04.073

International Journal of Cardiology
Volume 136, Issue 2 , Pages 165-170 , 14 August 2009

Article Tools

* Image Usage & Resolution